Global Postoperative Nausea and Vomiting Treatment Market, By Treatment Type (Serotonin Receptor Antagonists, Steroids, Dopamine Antagonists, Neurokinin NK-1 Receptor Antagonists, Non-pharmacological Treatment), Application (CINV, PONV, Motion Sickness, Pregnancy, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Postoperative Nausea and Vomiting Treatment Market
Global postoperative nausea and vomiting treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 13.20% in the above mentioned forecast period.
Postoperative nausea and vomiting (PONV) is used to describe nausea and vomiting or retching in the post-anesthesia care unit (PACU). The consequences of PONV include increased anxiety for future surgical procedures, more time consumption in recovery, hospital stay and some other severe consequences such as aspiration pneumonia, metabolic alkalosis, and surgical complications.
Rise in the prevalence of postoperative nausea and vomiting complications, growing demand for combination therapy, rise in the number of surgeries as a treatment option, rise in healthcare expenditure and growing government initiatives for spreading awareness are the factors that will expand the global postoperative nausea and vomiting treatment market.
Rising R&D activities, growing demand for advanced therapies, and more focus of major pharmaceutical companies towards novel treatment therapies will provide beneficial opportunities for the global postoperative nausea and vomiting treatment market in the forecast period of 2021-2028.
Strict regulatory approvals and high cost of treatment are the factors that will hamper the market growth and will further challenge the global postoperative nausea and vomiting treatment market in the forecast period mentioned above.
This Postoperative nausea and vomiting treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global postoperative nausea and vomiting treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Postoperative Nausea and Vomiting Treatment Market Scope and Market Size
The Postoperative nausea and vomiting treatment market is segmented on the basis of treatment type, application, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment type, the postoperative nausea and vomiting treatment market is segmented into serotonin receptor antagonists, steroids, dopamine antagonists, neurokinin NK-1 receptor antagonists, and non-pharmacological treatment. Serotonin receptor antagonists have been further sub-segmented into ramosetron, granisetron, palonosetron, ondansetron, dolasetron and tropisetron. Neurokinin NK-1 receptor have been further sub-segmented into antagonists aprepitant and rolapitant,
- On the basis of application, the postoperative nausea and vomiting treatment market is segmented into CINV, PONV, motion sickness, pregnancy, and others.
- On the basis of end-users, the postoperative nausea and vomiting treatment market is segmented into clinic, hospital, and others.
- The postoperative nausea and vomiting treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy, and online pharmacy.
Global Postoperative Nausea and Vomiting Treatment Market Country Level Analysis
Global postoperative nausea and vomiting treatment market is analyzed and market size information is provided by the country, treatment type, application, end-users, and distribution channel as referenced above.
The countries covered in the global postoperative nausea and vomiting treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the Postoperative nausea and vomiting treatment market due to the presence of major key players, continuous technological development, well-developed healthcare sector, increasing prevalence of disease and increasing awareness towards health in this region. Global postoperative nausea and vomiting treatment market in the Asia-Pacific and Europe is expected to grow during the forecast period due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global postoperative nausea and vomiting treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global postoperative Nausea and Vomiting Treatment Market Share Analysis
Global postoperative nausea and vomiting treatment market competitive landscape provides details by competitor. Pieces included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global postoperative nausea and vomiting treatment market.
The major players covered in the global postoperative nausea and vomiting treatment market report are Acacia Pharma Group Plc, Sanofi, Novartis AG, F. Hoffmann-La Roche Ltd., ANI Pharmaceuticals, Inc., Camurus AB, Helsinn Healthcare SA., Eisai Co., Ltd., Merck Sharp & Dohme Corp., Teva Pharmaceutical Industries Ltd., and GlaxoSmithKline plc, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-